Dietary Supplement
Alga Dunaliella Bardawil
Alga Dunaliella Bardawil is a dietary supplement with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_1
1
25%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Active, not recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
active_not_recruiting125%
completed250%
withdrawn125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_1
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil
NCT01680510
completednot_applicable
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa
NCT01256697
withdrawnphase_3
The Effect of Algae Dunaliella Bardawil on Psoriasis (2)
NCT01121081
completednot_applicable
Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene
NCT00569023
Clinical Trials (4)
Showing 4 of 4 trials
NCT01680510Phase 1
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil
NCT01256697Not Applicable
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa
NCT01121081Phase 3
The Effect of Algae Dunaliella Bardawil on Psoriasis (2)
NCT00569023Not Applicable
Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4